Dolby Laboratories, INC Form 4 insider transactions

Dolby Laboratories' SVP, Entertainment, John Couling, reported the acquisition and disposal of company stock and derivative securities, including the vesting of performance-based restricted stock units.

Todd Pendleton, SVP and Chief Marketing Officer at Dolby Laboratories, reported the acquisition and disposal of company stock and stock options, including performance-based restricted stock units.

Shriram Revankar, a Senior Vice President at Dolby Laboratories, reported the acquisition of restricted stock units and stock options, as well as the disposal of shares to cover taxes.

Dolby Laboratories' CFO, Robert Park, reported the acquisition of restricted stock units and stock options, as well as the withholding of shares for tax purposes.

Dolby Laboratories' EVP, General Counsel & Secretary, Mark Sherman, reported multiple transactions involving the company's Class A Common Stock, including the vesting of restricted stock units and stock option grants.

Dolby Laboratories CEO Kevin Yeaman reported the acquisition and disposal of company stock and stock options, including the vesting of performance-based restricted stock units.

Dolby Laboratories CEO Kevin Yeaman exercised stock options and sold shares, both directly and indirectly through a family trust.

Ryan Nicholson, VP, CAO and Corp. Controller at Dolby Laboratories, exercised stock options and sold shares on November 26, 2024.

Dolby Laboratories' SVP, Entertainment, John Couling, exercised stock options and sold shares of Class A Common Stock, according to a recent SEC filing.

Dolby Laboratories director Peter Gotcher sold 6,079 shares of Class A common stock at an average price of $78.9647 on November 21, 2024.

Dagmar Dolby, a director at Dolby Laboratories, converted 500,000 shares of Class B common stock to Class A common stock and then gifted them to a charitable organization.

Kevin Yeaman, CEO of Dolby Laboratories, files an amendment to a previous SEC Form 4 to include indirect holdings of Class A Common Stock by his son.

Dolby Laboratories CEO Kevin Yeaman exercised stock options and sold shares of Class A Common Stock on October 15, 2024, according to a recent SEC filing.

Robert Park, SVP & Chief Financial Officer of Dolby Laboratories, disposed of shares to cover withholding taxes related to vesting restricted stock units.

Dolby Laboratories CEO Kevin Yeaman reports an indirect purchase of Class A Common Stock by a family member, along with adjustments to his beneficial ownership.

Mark Andrew Sherman, EVP, Gen. Counsel & Secretary of Dolby Laboratories, exercised stock options and sold shares of Class A Common Stock on May 28, 2024.

Shriram Revankar, SVP at Dolby Laboratories, disposed of shares to cover withholding taxes related to vesting restricted stock units.

Dagmar Dolby, a director at Dolby Laboratories, converted 415,000 shares of Class B Common Stock to Class A and donated them to an unaffiliated charitable organization on May 13, 2024.

Director Emily Rollins sold 1,000 shares of Dolby Laboratories Class A Common Stock at $80.88 per share on March 1, 2024, according to a Form 4 filing.

Todd Pendleton, SVP and Chief Marketing Officer at Dolby Laboratories, reports the acquisition and disposal of Class A Common Stock and the exercise of employee stock options.